Alpha1Health.com | Information about Alpha-1 Antitrypsin Deficiency and Therapies | Resources From Baxter

Resources from Baxter

ARALAST AATmopshere ARALAST AATmosphere

A support program that helps you, your staff, and your patients live with AAT deficiency.

Learn More

AAT deficiency eLearning AAT deficiency eLearning

Baxter has created this interactive educational program to help healthcare professionals and others learn more about AAT deficiency.

Learn More

AlphaTest kit
AlphaTest® Kit

Baxter is pleased to offer complimentary AlphaTest® Kits to physicians.

Learn More   Order a kit

east start sample
Easy Start Sample Program

Baxter is offering Alpha-1 patients (who have not previously used ARALAST A1-PI) and their physicians the opportunity to receive up to a two-week sample supply for a no-charge trial.

Learn More   Download more information

education kit
AAT Physician Kit

The AAT Physician Kit is designed to help physicians with testing, diagnosis and management of AAT deficiency.

Learn more   Order a copy

Patient Stories DVD

Patient Stories DVD

Patients with Alpha-1 share their experiences on this DVD, which includes commentary from a pulmonary specialist.

Learn more   Order a copy

interview with dr. butler video

Interview with Dr. Butler

Watch expert educational commentary by Dr. John Butler, a pulmonary and critical care specialist.

Watch now

physician brochure

AAT Physician Brochure

A brochure is designed to help physicians with testing, diagnosis and management of AAT deficiency.

Learn more   Order a copy   Download a copy

physician brochure

AAT Patient Brochure

A brochure to share with patients and their families containing information about understanding, treating, and living with AAT deficiency.

Learn more   Order a copy   Download a copy

ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

adobe reader To view PDF, you will need Adobe® Acrobat® Reader® software.